within Pharmacolibrary.Drugs.ATC.S;

model S03AA08
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 0.29 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 1000 / 1000000,
    adminCount     = 1,
    Vd             = 0.00046,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Chloramphenicol is a broad-spectrum antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit. It was historically used to treat serious infections like typhoid fever and meningitis, but its use is now limited due to rare but serious adverse effects such as aplastic anemia. Chloramphenicol is still approved for certain severe infections where alternative antibiotics are ineffective or contraindicated.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult subjects after intravenous administration.</p><h4>References</h4><ol><li><p>Nahata, MC, &amp; Powell, DA (1983). Comparative bioavailability and pharmacokinetics of chloramphenicol after intravenous chloramphenicol succinate in premature infants and older patients. <i>Developmental pharmacology and therapeutics</i> 6(1) 23–32. DOI:<a href=&quot;https://doi.org/10.1159/000457274&quot;>10.1159/000457274</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/6839912/&quot;>https://pubmed.ncbi.nlm.nih.gov/6839912</a></p></li><li><p>Sullins, AK, &amp; Abdel-Rahman, SM (2013). Pharmacokinetics of antibacterial agents in the CSF of children and adolescents. <i>Paediatric drugs</i> 15(2) 93–117. DOI:<a href=&quot;https://doi.org/10.1007/s40272-013-0017-5&quot;>10.1007/s40272-013-0017-5</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/23529866/&quot;>https://pubmed.ncbi.nlm.nih.gov/23529866</a></p></li><li><p>Ambrose, PJ (1984). Clinical pharmacokinetics of chloramphenicol and chloramphenicol succinate. <i>Clinical pharmacokinetics</i> 9(3) 222–238. DOI:<a href=&quot;https://doi.org/10.2165/00003088-198409030-00004&quot;>10.2165/00003088-198409030-00004</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/6375931/&quot;>https://pubmed.ncbi.nlm.nih.gov/6375931</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end S03AA08;
